Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women ≤55 years of age

Circulation

Volumn 94, Issue 6, 1996, Pages 1263-1268

  Sunayama, Satoshi ^a   Daida, Hiroyuki ^a   Mokuno, Hiroshi ^a   Miyano, Hiroshi ^a   Yokoi, Hisashi ^a   Lee, Young Joon ^a   Sakurai, Hidehiko ^a   Yamaguchi, Hiroshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

aging; coronary disease; lipoprotein(a); risk factors; women

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AGING; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 0029794569     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.6.1263     Document Type: Article

References (47)

1. Berg K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand. 1963;59:369-382.
2. Gaubatz JW, Heideman C, Gotto AMJ, Morrisett JD, Dahlen GH. Human plasma lipoprotein(a) structural properties. J Biol Chem. 1983;258:4582-4589.
3. Utermann G, Weber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett. 1983;154:357-361.
4. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;300:132-137.
5. Loscalzo J, Weinfeld M, Fless GM, Scanu A. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis. 1990;10:240-245.
6. Utermann G. The mysteries of lipoprotein(a). Science. 1989;246:904-910.
7. Loscalzo J. Lipoprotein(a): a unique risk factor for atherothrombotic disease. Arteriosclerosis. 1990;10:672-679.
8. Scanu AM. Lipoprotein (a): a genetic risk factor for premature coronary heart disease. JAMA. 1992;267:3326-3329.
9. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AMJ. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74:758-765.
10. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, Utermann G. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med. 1990;322:1494-1499.
11. Schwartzkopff W, Schleicher J, Pottins I, Yu SB, Han CZ, Du DY. Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction. Atherosclerosis, 1990;82:253-259.
12. Genest JJ, Jenner JL, McNamara JR, Ordovas JM, Silberman SR, Wilson PWF, Schaefer EJ. Prevalence of lipoprotein(a) [Lp(a)] excess in coronary artery disease. Am J Cardiol. 1991;67:1039-1045.
13. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Utermann G. Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb. 1992;12:1214-1226.
14. Labeur C, De Bacquer D, De Backer G, Vincke J, Muyldermans L, Vandekerckhove Y, Van der Stichele E, Rosseneu M. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem. 1992;38:2261-2266.
15. Kark JD, Sandholzer C, Friedlander Y, Utermann G. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. Atherosclerosis. 1993;98:139-151.
16. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 1986;256:2540-2544.
17. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels. Atherosclerosis. 1986;62:249-257.
18. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem. 1990;36:2023.
19. Genest JJ, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, Wilson PWF, Salem DS, Schaefer EJ. Lipoprotein cholesterol, apolipoproteins A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol. 1992;19:792-802.
20. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 1993;153:2209-2216.
21. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DRJ, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15.
22. Simons L, Friedlander Y, Simons J, McCallum J. Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study. Atherosclerosis. 1993;99:87-95.
23. Kario K, Matsuo T, Imiya M, Kayaba K, Kuroda T, Nago N, Matsuo H, Shimada K. Close relation between lipoprotein(a) levels and atherothrombotic disease in Japanese subjects > 75 years of age. Am J Cardiol. 1994;73:1187-1190.
24. Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med. 1989;226:271-276.
25. Gurakar A, Hoeg JM, Kostner G, Papadopoulos NM, Brewer HBJ. Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. Atherosclerosis. 1985;57:293-301.
26. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 1989;78:145-150.
27. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LSC, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51:7-40.
28. Fless GM, Snyder ML, Scanu AM. Enzyme-linked immunoassay for Lp(a). J Lipid Res. 1989;30:651-662.
29. Fujita S, Sano T, Katayama Y. Measurement of serum Lp(a) by COBAS MIRA using a latex immunoturbidimetric assay kit. J Clin Lab Anal. 1994;8:385-390.
30. Abe A, Noma A. Studies on apolipoprotein(a) phenotypes, 1: phenotype frequencies in a healthy Japanese population. Atherosclerosis. 1992;96:1-8.
31. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
32. Barret-Conner E, Bush IL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
33. Wallis C. The estrogen dilemma. Time June 16, 1995.
34. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis. 1986;59:199-204.
35. Solymoss BC, Marcil M, Wesolowska E, Gilfix BM, Lesperance J, Campeau L. Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio. Am J Cardiol. 1993;72:1215-1219.
36. Bostom AG, Gangnon DR, Cupples LA, Wilson PWF, Jenner JL, Ordovas JM, Schaefer EJ, Castelli WP. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: the Framingham Heart Study. Circulation. 1994;90:1688-1695.
37. Grundy SM. National Cholesterol Education Program: second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1329-1445.
38. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328:1069-1075.
39. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
40. Soma MR, Osnago-Gadda I, Paoletti R, Fumagalli R, Morrisett JD, Meschia M, Crosignani P. The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med. 1993;153:1462-1468.
41. Samaan SA, Crawford MH. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol. 1995;26:1403-1410.
42. Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995;92:24-30.
43. McKinlay S, Jefferys M, Thompson B. An investigation of the age at menopause. J Biosoc Sci. 1972;4:161-173.
44. Bengtsson C, Lindquist O, Redvall L. Menstrual status and menopausal age of middle-aged Swedish women: a population study of women in Goteborg 1968-69 and 1974-75. Acta Obstet Gynecol Scand. 1981;60:269-275.
45. Ushiroyama T, Okamoto Y, Sugimoto O. Plasma lipid and lipoprotein levels in perimenopausal women: clinical reserch in 1198 Japanese women. Acta Obstet Gynecol Scand. 1993;72:428-433.
46. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AMJ, Patsch W. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1993;13:1139-1158.
47. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PWF, Castelli WP, Schaefer EJ. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels: the Framingham Offspring Study. Circulation. 1993;87:1135-1141.